Decitabine-based chemotherapy followed by haploidentical lymphocyte infusion improves the effectiveness in elderly patients with acute myeloid leukemia

In this study, we first initiated a multicenter, single-arm, phase-II clinical trial using decitabine (DAC) (20mg/m(2) for five days) based chemotherapy, followed by haploidentical lymphocyte infusion (HLI) that was applied as induction therapy for elderly patients with AML. Furthermore, the role of...

Descripción completa

Detalles Bibliográficos
Autores principales: Jing, Yu, Jin, Xiangshu, Wang, Lixin, Dou, Liping, Wang, Quanshun, Yao, Yushi, Lian, Shimei, Zhou, Jihao, Zhu, Haiyan, Yao, Zilong, Gao, Lijun, Wang, Lili, Li, Yonghui, Bai, Xuefeng, Fang, Meiyun, Yu, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581138/
https://www.ncbi.nlm.nih.gov/pubmed/28881839
http://dx.doi.org/10.18632/oncotarget.11183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581138/
https://www.ncbi.nlm.nih.gov/pubmed/28881839
http://dx.doi.org/10.18632/oncotarget.11183

Ejemplares similares